Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Management of patients eligible for proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors: economic impact and reform proposalsGlobal & regional health technology assessment (Online), 2019-07, Vol.2019, p.228424031986137 [Peer Reviewed Journal]The Author(s) 2019 ;ISSN: 2284-2403 ;EISSN: 2283-5733 ;DOI: 10.1177/2284240319861375Full text available |
|
2 |
Material Type: Article
|
Severe haematological toxicities in relapsed ovarian cancer treated with olaparib or niraparib: an Italian cost-minimization analysisGlobal & regional health technology assessment (Online), 2019-05, Vol.2019, p.228424031984394 [Peer Reviewed Journal]The Author(s) 2019 ;ISSN: 2284-2403 ;EISSN: 2283-5733 ;DOI: 10.1177/2284240319843941Full text available |
|
3 |
Material Type: Article
|
Clinical and Economic Management of Uterine Fibroids: The Point of View of a Decision Makers BoardGlobal & regional health technology assessment (Online), 2016-11, Vol.3 (3), p.GRHTA.5000223 [Peer Reviewed Journal]2016 SAGE Publications Inc ;ISSN: 2284-2403 ;EISSN: 2283-5733 ;DOI: 10.5301/GRHTA.5000223Full text available |
|
4 |
Material Type: Article
|
Prevalence, Costs and Consequences of “Manovra AIFA” for ICS-LABA Treatment in Patients with Asthma or COPD: A Real-Practice AnalysisGlobal & regional health technology assessment (Online), 2016-11, Vol.3 (3), p.GRHTA.5000235 [Peer Reviewed Journal]2016 SAGE Publications Inc ;ISSN: 2284-2403 ;EISSN: 2283-5733 ;DOI: 10.5301/GRHTA.5000235Full text available |
|
5 |
Material Type: Article
|
Difficulties and Challenges in the Management of Market Access for Innovative Oncological TherapiesGlobal & regional health technology assessment (Online), 2016-11, Vol.3 (3), p.GRHTA.5000237 [Peer Reviewed Journal]2016 SAGE Publications Inc ;ISSN: 2284-2403 ;EISSN: 2283-5733 ;DOI: 10.5301/GRHTA.5000237Full text available |
|
6 |
Material Type: Article
|
Evolution of the Healthcare Expenditure in Italy and Effects of Fingolimod Increased Prescribing in Second Line Treatment of Relapsing-Remitting Multiple SclerosisGlobal & regional health technology assessment (Online), 2016-11, Vol.3 (3), p.GRHTA.5000232 [Peer Reviewed Journal]2016 SAGE Publications Inc ;ISSN: 2284-2403 ;EISSN: 2283-5733 ;DOI: 10.5301/GRHTA.5000232Full text available |
|
7 |
Material Type: Article
|
Cost-Effectiveness Analysis of Triptorelin versus Leuprolide in the Treatment of Advanced Prostate CancerGlobal & regional health technology assessment (Online), 2016-11, Vol.3 (3), p.GRHTA.5000224 [Peer Reviewed Journal]2016 SAGE Publications Inc ;ISSN: 2284-2403 ;EISSN: 2283-5733 ;DOI: 10.5301/GRHTA.5000224Full text available |
|
8 |
Material Type: Article
|
Observational Analysis of Antineoplastic and Immunomodulating Drug Expenditure in Two Local Health Units in Northern Italy during the Period 2009-2011Global & regional health technology assessment (Online), 2016-11, Vol.3 (3), p.GRHTA.5000231 [Peer Reviewed Journal]2016 SAGE Publications Inc ;ISSN: 2284-2403 ;EISSN: 2283-5733 ;DOI: 10.5301/GRHTA.5000231Full text available |
|
9 |
Material Type: Article
|
Economical Evaluation of the Sustain Program for the Out-of-Hospital Administration of Abatacept for Rheumatoid ArthritisGlobal & regional health technology assessment (Online), 2016-11, Vol.3 (3), p.GRHTA.5000236 [Peer Reviewed Journal]2016 SAGE Publications Inc ;ISSN: 2284-2403 ;EISSN: 2283-5733 ;DOI: 10.5301/GRHTA.5000236Full text available |